Incidence and risk factors for hemorrhagic cystitis in unmanipulated haploidentical transplant recipients.
Fiche publication
Date publication
décembre 2015
Journal
Transplant infectious disease : an official journal of the Transplantation Society
Auteurs
Membres identifiés du Cancéropôle Est :
Pr RUBIO Marie Thérèse
Tous les auteurs :
Ruggeri A, Roth-Guepin G, Battipaglia G, Mamez AC, Malard F, Gomez A, Brissot E, Belhocine R, Vekhoff A, Lapusan S, Isnard F, Legrand O, Gozlan J, Boutolleau D, Ledraa T, Labopin M, Rubio MT, Mohty M
Lien Pubmed
Résumé
Hemorrhagic cystitis (HC) is a common complication after hematopoietic allogeneic stem cell transplantation (HSCT) associated with intensity of the conditioning regimen, cyclophosphamide (Cy) therapy, and BK polyomavirus (BKPyV) infection.
Mots clés
Adolescent, Adult, Aged, Cystitis, etiology, Graft vs Host Disease, prevention & control, Haplotypes, Hematopoietic Stem Cell Transplantation, adverse effects, Hemorrhage, Humans, Immunosuppressive Agents, pharmacology, Incidence, Middle Aged, Risk Factors, Young Adult
Référence
Transpl Infect Dis. 2015 Dec;17(6):822-30